Gerd Klausen

640 total citations
9 papers, 385 citations indexed

About

Gerd Klausen is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Gerd Klausen has authored 9 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Gerd Klausen's work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (6 papers) and HIV/AIDS drug development and treatment (3 papers). Gerd Klausen is often cited by papers focused on Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (6 papers) and HIV/AIDS drug development and treatment (3 papers). Gerd Klausen collaborates with scholars based in Germany, Spain and Australia. Gerd Klausen's co-authors include Stefan Mauss, Thomas A. Lutz, Michael J. Kuiper, Marina Núñez, Stephen Locarnini, Berta Rodés, Angeline Bartholomeusz, Frank Tacke, Julie Sheldon and Nuria Camino and has published in prestigious journals such as Hepatology, Journal of Hepatology and AIDS.

In The Last Decade

Gerd Klausen

9 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerd Klausen Germany	6	344	327	143	31	11	9	385
Rob Elston United States	5	292 0.8×	263 0.8×	103 0.7×	25 0.8×	33 3.0×	7	323
Évelyne Schvoerer France	10	175 0.5×	168 0.5×	85 0.6×	49 1.6×	9 0.8×	15	226
Ana Arias Spain	7	192 0.6×	175 0.5×	105 0.7×	44 1.4×	5 0.5×	12	279
Elena Losada Spain	6	225 0.7×	206 0.6×	160 1.1×	96 3.1×	9 0.8×	9	312
Pilar Ríos Spain	12	420 1.2×	391 1.2×	197 1.4×	65 2.1×	7 0.6×	13	497
Ellen Xia United States	9	271 0.8×	205 0.6×	167 1.2×	20 0.6×	13 1.2×	13	296
Krishna Chodavarapu United States	8	335 1.0×	292 0.9×	103 0.7×	11 0.4×	20 1.8×	10	346
Vithika Suri United States	9	263 0.8×	264 0.8×	52 0.4×	12 0.4×	6 0.5×	40	350
Dorothée Obach France	8	158 0.5×	172 0.5×	48 0.3×	26 0.8×	14 1.3×	12	238
C. Mayerat Switzerland	7	317 0.9×	314 1.0×	36 0.3×	12 0.4×	6 0.5×	9	354

Countries citing papers authored by Gerd Klausen

Since Specialization

Citations

This map shows the geographic impact of Gerd Klausen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Klausen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Klausen more than expected).

Fields of papers citing papers by Gerd Klausen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Klausen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Klausen. The network helps show where Gerd Klausen may publish in the future.

Co-authorship network of co-authors of Gerd Klausen

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Klausen. A scholar is included among the top collaborators of Gerd Klausen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Klausen. Gerd Klausen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Bischoff, Jenny, Stefan Mauss, Thomas A. Lutz, et al.. (2021). Late presentation of chronic hepatitis C patients in the era of direct‐acting antivirals—Data from the German Hepatitis C‐Registry. Journal of Viral Hepatitis. 28(11). 1660–1664. 2 indexed citations

Dupke, S, Matthias Freiwald, Gerd Klausen, et al.. (2010). Clinical application of genotypic co‐receptor tropism testing from viral RNA and proviral DNA: week 24 analysis of the Berlin maraviroc cohort. Journal of the International AIDS Society. 13(S4). 9 indexed citations

Rockstroh, Jürgen K., M. Vogel, Gerd Klausen, et al.. (2007). [636] THE INFLUENCE OF NUCLEOSIDE FREE HAART ON THE TREATMENT OF CHRONIC HEPATITIS C WITH PEGYLATED INTERFERON/RIBAVIRIN COMBINATION TREATMENT. Journal of Hepatology. 46. S240–S240. 1 indexed citations

Nattermann, Jacob, Martin Vogel, Thomas Berg, et al.. (2007). Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients. Hepatology. 46(4). 1016–1025. 35 indexed citations

Klausen, Gerd, et al.. (2006). Therapie der chronischen Hepatitis C bei HIV/HCV-koinfizierten Drogenabhängigen. Suchttherapie. 7(1). 2–7. 2 indexed citations

Vogel, Martin, Jacob Nattermann, Axel Baumgarten, et al.. (2006). Pegylated Interferon-α for the Treatment of Sexually Transmitted Acute Hepatitis C in HIV-Infected Individuals. Antiviral Therapy. 11(8). 1097–1102. 52 indexed citations

Voigt, Esther, Christian Schulz, Gerd Klausen, et al.. (2005). Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients. Journal of Infection. 53(1). 36–42. 30 indexed citations

Sheldon, Julie, Nuria Camino, Berta Rodés, et al.. (2005). Selection of Hepatitis B Virus Polymerase Mutations in HIV-Coinfected Patients Treated with Tenofovir. Antiviral Therapy. 10(6). 727–734. 223 indexed citations

Rockstroh, Jürgen K., Mathias Lichterfeld, Hans Dieter Nischalke, et al.. (2002). Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients. AIDS. 16(15). 2083–2085. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact